Share on StockTwits

Molina Healthcare (NYSE:MOH)’s share price hit a new 52-week high during trading on Friday , reports. The stock traded as high as $45.57 and last traded at $45.32, with a volume of 220,962 shares changing hands. The stock had previously closed at $45.26.

A number of research firms have recently commented on MOH. Analysts at Cantor Fitzgerald raised their price target on shares of Molina Healthcare from $35.00 to $40.00 in a research note on Thursday, May 15th. Separately, analysts at Zacks reiterated a “neutral” rating on shares of Molina Healthcare in a research note on Monday, May 5th. They now have a $41.00 price target on the stock. Finally, analysts at Deutsche Bank raised their price target on shares of Molina Healthcare from $36.00 to $40.00 in a research note on Friday, May 2nd. They now have a “hold” rating on the stock. Seven analysts have rated the stock with a hold rating and six have given a buy rating to the company. The company presently has a consensus rating of “Hold” and a consensus target price of $42.83.

The stock’s 50-day moving average is $42.52 and its 200-day moving average is $37.57. The company has a market cap of $2.118 billion and a price-to-earnings ratio of 76.45.

Molina Healthcare (NYSE:MOH) last announced its earnings results on Thursday, May 1st. The company reported $0.10 EPS for the quarter, beating the Thomson Reuters consensus estimate of ($0.01) by $0.11. The company had revenue of $2.07 billion for the quarter, compared to the consensus estimate of $2.06 billion. During the same quarter in the prior year, the company posted $0.64 earnings per share. The company’s quarterly revenue was up 30.1% on a year-over-year basis. On average, analysts predict that Molina Healthcare will post $2.02 earnings per share for the current fiscal year.

Molina Healthcare, Inc provides medicaid-related solutions. The Company operates in two segments: Health Plans and Molina Medicaid Solutions.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.